Conceptus CEO hired
This article was originally published in The Gray Sheet
Executive Summary
Former Bausch & Lomb President, Americas, Mark Sieczkarek, 48, is appointed president, CEO and board member of the Essure non-incisional birth control company, effective April 17. Former president and CEO Steven Bacich will become the firm's chief technology officer. The San Carlos, Calif. firm says Sieczkarek's experience in overseeing the launch of B&L's Zyoptix laser for LASIK eye surgery will serve him in marketing Essure, approved last November (1"The Gray Sheet" Nov. 11, 2002, p. 16)...
You may also be interested in...
Conceptus Essure Contraceptive Approved Three Months Post-Panel Review
FDA's approval of Conceptus' Essure non-incisional permanent birth control device includes a requirement that the company document the placement failure rate with newly trained physicians and identify factors associated with the failure, the agency notes in a Nov. 4 "talk paper" announcing the approval
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.